the publication�s purpose is to be a "force for good and a platform for much needed change and to generate critical debate"...
now the country may face a fine of millions of euros after its dereliction was referred to the european court of justice (ecj), the guardian reports..
in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..
..
sponsored by an innovative medicines canada company .
the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes...